ROS‐scavenging nanozymes with the specific action of mimicking SOD and CAT and protecting against ROS damage are promising targets in treating cardiac ischemic injury.[112] Nanozymes possess unique physicochemical properties and bioactivities that provide innovative opportunities to overcome the challenges in myocardial ischemia. This evidence concerns the gene SOD1 and myocardial ischemia.